Back to Results
First PageMeta Content
Health / Food and Drug Administration / Clinical pharmacology / Therapeutics / United States Public Health Service / KV Pharmaceutical / 17-Hydroxyprogesterone caproate / Compounding / FDA Warning Letter / Pharmacology / Pharmaceutical sciences / Clinical research


USCA Case #[removed]Document #[removed]Filed: [removed]
Add to Reading List

Document Date: 2014-12-17 12:04:58


Open Document

File Size: 126,34 KB

Share Result on Facebook

City

Washington / DC / Seabrook / N.W. Washington / /

Company

KV PHARMACEUTICAL COMPANY AND THER-RX CORPORATION / Pharmacy Inc. / Dole / Intelligence Inc. / M. COOPER WILLIAMS & CONNOLLY LLP / Appellants K-V Pharmaceutical Company / Jerome Stevens Pharmaceuticals Inc. / 43 Teva Pharmaceutical Industries Ltd. / THER-RX CORPORATION / Schering Corp. / Crowley Caribbean Transport Inc. / OSG Bulk Ships Inc. / /

Country

United States / /

Currency

pence / /

Event

FDA Phase / /

Facility

United States Court of Appeals / Washington Legal Clinic / Pharmacy Compounding / /

IndustryTerm

web site search results / /

Organization

Federal Communications Commission / Federal Authority / US Federal Reserve / United States Court of Appeals / Center for Auto Safety / DEPARTMENT OF HEALTH / UNITED STATES FOOD AND DRUG ADMINISTRATION / Environmental Protection Agency / /

Person

Bush / AMY BERMAN JACKSON / Sherrod Brown / MARGARET HAMBURG / KATHLEEN SEBELIUS / Margaret A. Hamburg / /

Position

SECRETARY OF HEALTH / Queen / COMMISSIONER / /

Product

Suspected Infections Following Steroid Injections / to / /

ProvinceOrState

Columbia Circuit KV PHARMACEUTICAL COMPANY / DISTRICT OF COLUMBIA / South Carolina / A. B. / Washington / DC / /

Technology

http / dtd / pdf / /

URL

http /

SocialTag